Adrián LLerena is the Director of INUBE Extremadura Biosanitary Research Institute and the Clinical Research Center in the University Hospital, Badajoz Spain. He is also Professor of Pharmacology and Clinical Pharmacology in the Medical School of the University of Extremadura Spain and it was part time in the University of Beira Interior, Portugal, between 1989 to 1993 did his post doc at Karolinska Institute Sweden focusing on Clinical Pharmacogenetics. He has also been Visiting Professor in different Universities in USA such as University of California at Los Angeles 2004 Mount Sinai Medical School at NY 2005 and Miller Medical School at Miami 2006, UNC North Caroline and in Latin America such as UNAM in Mexico San Marcos in Peru Chile Brazil etc. He is also coordinating the RIBEF Ibero-American network of Pharmacogenetics since 2006. He served in different Scientific societies as Ibero-American Society of Pharmacogenomics. Former Vice-president of the Spanish Society of Clinicial Pharmacology and President of the Spanish Society for Pharmacogenetics and Pharmacogenomics (2019-23). Coordinator of the IMPaCT WP05-BioFRAM-MedeA Pharmacogenetics Implementation Projects in Spanish Health System.

Prof. Collen Masimirembwa is the founding President and CEO of the African Institute of Biomedical Science and Technology (AiBST) in Zimbabwe. AiBST has a mission to develop life transforming healthcare solutions for Africa. Collen developed the first registered clinical pharmacogenetic testing panel and dosing algorithm in Africa, GenoPharmR, that is inclusive of genetic variations unique to people of African ancestry. Collen was awarded the GATES Foundation Calestous Juma Award to expand clinical pharmacogenetic testing in Africa and build an ecosystem for drug discovery and development.

Sophie Stocker is an Associate Professor in the Sydney Pharmacy School. She is also an Honorary Senior Hospital Scientist in the Department of Clinical Pharmacology and Toxicology at St Vincent’s Hospital, Sydney; an Adjunct Senior Lecturer of the St Vincent’s Clinical School, University of New South Wales; and an Honorary Scientist at the Garvan Medical Research Institute. Her research program involves clinical and experimental pharmacology, ethnopharmacology, pharmacogenomics, pharmacometrics and qualitative research on the impact of intrinsic and extrinsic factors on drug disposition, efficacy and safety. Her research focuses on understanding variability in response to medicines and how this can be managed to optimise patient care.